US Stock MarketDetailed Quotes
COCP Cocrystal Pharma
- 1.9650
- -0.1350-6.43%
Close May 16 16:00 ET
19.99MMarket Cap-1050P/E (TTM)
2.1000High1.9323Low24.26KVolume2.1000Open2.1000Pre Close48.63KTurnover0.34%Turnover RatioLossP/E (Static)10.17MShares3.285052wk High0.76P/B13.95MFloat Cap1.325052wk Low--Dividend TTM7.10MShs Float77.4000Historical High--Div YieldTTM7.99%Amplitude1.3250Historical Low2.0040Avg Price1Lot Size
About Cocrystal Pharma Company
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
Company Profile
SymbolCOCP
Company NameCocrystal Pharma
Listing DateMar 12, 2018
Founded2014
CEODr. Gary L. Wilcox
MarketNASDAQ
Employees12
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address19805 North Creek Parkway
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-305-425-1780
Company Executives
- Name
- Position
- Salary
- Dr. Sam Lee, PhD
- President and Co-Chief Executive Officer
- 627.20K
- James J. Martin
- Co-Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
- 627.20K
- Dr. Roger D. Kornberg, PhD
- Chairman of the Board
- 184.84K
- Dr. Anthony Japour, M.D.
- Independent Director
- 79.97K
- Steven D. Rubin
- Independent Director
- 113.51K
- Richard C. Pfenniger, Jr
- Independent Director
- 44.23K
- Fred Hassan
- Independent Director
- 49.47K
- Dr. Phillip Frost, M.D.
- Independent Director
- 84.12K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
